img

Global GnRH Receptor Antagonists Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global GnRH Receptor Antagonists Market Insights, Forecast to 2034

GnRH antagonists are synthetic analogs of GnRH that bind to the GnRH receptors in the pituitary, rapidly suppressing the secretion of gonadotropins.
Global GnRH Receptor Antagonists market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, GnRH Receptor Antagonists industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, GnRH Receptor Antagonists key manufacturers include AbbVie, Takeda, Astellas, Kissei, Veru Inc, Myovant Sciences, AstraZeneca, Ferring Pharmaceuticals and Jiangsu Hengrui Medicine Co, etc. AbbVie, Takeda, Astellas are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of GnRH Receptor Antagonists were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole GnRH Receptor Antagonists market and estimated to attract more attentions from industry insiders and investors.
GnRH Receptor Antagonists can be divided into Peptides and Small Molecules, etc. Peptides is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
GnRH Receptor Antagonists is widely used in various fields, such as Prostate Cancer, Endometriosis, Uterine Fibroids and Female Infertility, etc. Prostate Cancer provides greatest supports to the GnRH Receptor Antagonists industry development. In 2022, global % sales of GnRH Receptor Antagonists went into Prostate Cancer filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global GnRH Receptor Antagonists market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global GnRH Receptor Antagonists market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


AbbVie
Takeda
Astellas
Kissei
Veru Inc
Myovant Sciences
AstraZeneca
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co
Segment by Type
Peptides
Small Molecules

Segment by Application


Prostate Cancer
Endometriosis
Uterine Fibroids
Female Infertility
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ GnRH Receptor Antagonists plant distribution, commercial date of GnRH Receptor Antagonists, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, GnRH Receptor Antagonists introduction, etc. GnRH Receptor Antagonists Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of GnRH Receptor Antagonists
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 GnRH Receptor Antagonists Product Introduction
1.2 Market by Type
1.2.1 Global GnRH Receptor Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Peptides
1.2.3 Small Molecules
1.3 Market by Application
1.3.1 Global GnRH Receptor Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Prostate Cancer
1.3.3 Endometriosis
1.3.4 Uterine Fibroids
1.3.5 Female Infertility
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global GnRH Receptor Antagonists Sales Estimates and Forecasts 2018-2029
2.2 Global GnRH Receptor Antagonists Revenue by Region
2.2.1 Global GnRH Receptor Antagonists Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global GnRH Receptor Antagonists Revenue by Region (2018-2024)
2.2.3 Global GnRH Receptor Antagonists Revenue by Region (2024-2029)
2.2.4 Global GnRH Receptor Antagonists Revenue Market Share by Region (2018-2029)
2.3 Global GnRH Receptor Antagonists Sales Estimates and Forecasts 2018-2029
2.4 Global GnRH Receptor Antagonists Sales by Region
2.4.1 Global GnRH Receptor Antagonists Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global GnRH Receptor Antagonists Sales by Region (2018-2024)
2.4.3 Global GnRH Receptor Antagonists Sales by Region (2024-2029)
2.4.4 Global GnRH Receptor Antagonists Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global GnRH Receptor Antagonists Sales by Manufacturers
3.1.1 Global GnRH Receptor Antagonists Sales by Manufacturers (2018-2024)
3.1.2 Global GnRH Receptor Antagonists Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of GnRH Receptor Antagonists in 2022
3.2 Global GnRH Receptor Antagonists Revenue by Manufacturers
3.2.1 Global GnRH Receptor Antagonists Revenue by Manufacturers (2018-2024)
3.2.2 Global GnRH Receptor Antagonists Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by GnRH Receptor Antagonists Revenue in 2022
3.3 Global Key Players of GnRH Receptor Antagonists, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global GnRH Receptor Antagonists Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global GnRH Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of GnRH Receptor Antagonists, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of GnRH Receptor Antagonists, Product Offered and Application
3.8 Global Key Manufacturers of GnRH Receptor Antagonists, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global GnRH Receptor Antagonists Sales by Type
4.1.1 Global GnRH Receptor Antagonists Historical Sales by Type (2018-2024)
4.1.2 Global GnRH Receptor Antagonists Forecasted Sales by Type (2024-2029)
4.1.3 Global GnRH Receptor Antagonists Sales Market Share by Type (2018-2029)
4.2 Global GnRH Receptor Antagonists Revenue by Type
4.2.1 Global GnRH Receptor Antagonists Historical Revenue by Type (2018-2024)
4.2.2 Global GnRH Receptor Antagonists Forecasted Revenue by Type (2024-2029)
4.2.3 Global GnRH Receptor Antagonists Revenue Market Share by Type (2018-2029)
4.3 Global GnRH Receptor Antagonists Price by Type
4.3.1 Global GnRH Receptor Antagonists Price by Type (2018-2024)
4.3.2 Global GnRH Receptor Antagonists Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global GnRH Receptor Antagonists Sales by Application
5.1.1 Global GnRH Receptor Antagonists Historical Sales by Application (2018-2024)
5.1.2 Global GnRH Receptor Antagonists Forecasted Sales by Application (2024-2029)
5.1.3 Global GnRH Receptor Antagonists Sales Market Share by Application (2018-2029)
5.2 Global GnRH Receptor Antagonists Revenue by Application
5.2.1 Global GnRH Receptor Antagonists Historical Revenue by Application (2018-2024)
5.2.2 Global GnRH Receptor Antagonists Forecasted Revenue by Application (2024-2029)
5.2.3 Global GnRH Receptor Antagonists Revenue Market Share by Application (2018-2029)
5.3 Global GnRH Receptor Antagonists Price by Application
5.3.1 Global GnRH Receptor Antagonists Price by Application (2018-2024)
5.3.2 Global GnRH Receptor Antagonists Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada GnRH Receptor Antagonists Market Size by Type
6.1.1 US & Canada GnRH Receptor Antagonists Sales by Type (2018-2029)
6.1.2 US & Canada GnRH Receptor Antagonists Revenue by Type (2018-2029)
6.2 US & Canada GnRH Receptor Antagonists Market Size by Application
6.2.1 US & Canada GnRH Receptor Antagonists Sales by Application (2018-2029)
6.2.2 US & Canada GnRH Receptor Antagonists Revenue by Application (2018-2029)
6.3 US & Canada GnRH Receptor Antagonists Market Size by Country
6.3.1 US & Canada GnRH Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada GnRH Receptor Antagonists Sales by Country (2018-2029)
6.3.3 US & Canada GnRH Receptor Antagonists Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe GnRH Receptor Antagonists Market Size by Type
7.1.1 Europe GnRH Receptor Antagonists Sales by Type (2018-2029)
7.1.2 Europe GnRH Receptor Antagonists Revenue by Type (2018-2029)
7.2 Europe GnRH Receptor Antagonists Market Size by Application
7.2.1 Europe GnRH Receptor Antagonists Sales by Application (2018-2029)
7.2.2 Europe GnRH Receptor Antagonists Revenue by Application (2018-2029)
7.3 Europe GnRH Receptor Antagonists Market Size by Country
7.3.1 Europe GnRH Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe GnRH Receptor Antagonists Sales by Country (2018-2029)
7.3.3 Europe GnRH Receptor Antagonists Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China GnRH Receptor Antagonists Market Size
8.1.1 China GnRH Receptor Antagonists Sales (2018-2029)
8.1.2 China GnRH Receptor Antagonists Revenue (2018-2029)
8.2 China GnRH Receptor Antagonists Market Size by Application
8.2.1 China GnRH Receptor Antagonists Sales by Application (2018-2029)
8.2.2 China GnRH Receptor Antagonists Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia GnRH Receptor Antagonists Market Size by Type
9.1.1 Asia GnRH Receptor Antagonists Sales by Type (2018-2029)
9.1.2 Asia GnRH Receptor Antagonists Revenue by Type (2018-2029)
9.2 Asia GnRH Receptor Antagonists Market Size by Application
9.2.1 Asia GnRH Receptor Antagonists Sales by Application (2018-2029)
9.2.2 Asia GnRH Receptor Antagonists Revenue by Application (2018-2029)
9.3 Asia GnRH Receptor Antagonists Sales by Region
9.3.1 Asia GnRH Receptor Antagonists Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia GnRH Receptor Antagonists Revenue by Region (2018-2029)
9.3.3 Asia GnRH Receptor Antagonists Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America GnRH Receptor Antagonists Market Size by Type
10.1.1 Middle East, Africa and Latin America GnRH Receptor Antagonists Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America GnRH Receptor Antagonists Market Size by Application
10.2.1 Middle East, Africa and Latin America GnRH Receptor Antagonists Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America GnRH Receptor Antagonists Sales by Country
10.3.1 Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America GnRH Receptor Antagonists Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Overview
11.1.3 AbbVie GnRH Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 AbbVie GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AbbVie Recent Developments
11.2 Takeda
11.2.1 Takeda Company Information
11.2.2 Takeda Overview
11.2.3 Takeda GnRH Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Takeda GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Takeda Recent Developments
11.3 Astellas
11.3.1 Astellas Company Information
11.3.2 Astellas Overview
11.3.3 Astellas GnRH Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Astellas GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Astellas Recent Developments
11.4 Kissei
11.4.1 Kissei Company Information
11.4.2 Kissei Overview
11.4.3 Kissei GnRH Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Kissei GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kissei Recent Developments
11.5 Veru Inc
11.5.1 Veru Inc Company Information
11.5.2 Veru Inc Overview
11.5.3 Veru Inc GnRH Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Veru Inc GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Veru Inc Recent Developments
11.6 Myovant Sciences
11.6.1 Myovant Sciences Company Information
11.6.2 Myovant Sciences Overview
11.6.3 Myovant Sciences GnRH Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Myovant Sciences GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Myovant Sciences Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Overview
11.7.3 AstraZeneca GnRH Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 AstraZeneca GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 AstraZeneca Recent Developments
11.8 Ferring Pharmaceuticals
11.8.1 Ferring Pharmaceuticals Company Information
11.8.2 Ferring Pharmaceuticals Overview
11.8.3 Ferring Pharmaceuticals GnRH Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Ferring Pharmaceuticals GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ferring Pharmaceuticals Recent Developments
11.9 Jiangsu Hengrui Medicine Co
11.9.1 Jiangsu Hengrui Medicine Co Company Information
11.9.2 Jiangsu Hengrui Medicine Co Overview
11.9.3 Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Jiangsu Hengrui Medicine Co Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 GnRH Receptor Antagonists Industry Chain Analysis
12.2 GnRH Receptor Antagonists Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 GnRH Receptor Antagonists Production Mode & Process
12.4 GnRH Receptor Antagonists Sales and Marketing
12.4.1 GnRH Receptor Antagonists Sales Channels
12.4.2 GnRH Receptor Antagonists Distributors
12.5 GnRH Receptor Antagonists Customers
13 Market Dynamics
13.1 GnRH Receptor Antagonists Industry Trends
13.2 GnRH Receptor Antagonists Market Drivers
13.3 GnRH Receptor Antagonists Market Challenges
13.4 GnRH Receptor Antagonists Market Restraints
14 Key Findings in The Global GnRH Receptor Antagonists Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global GnRH Receptor Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Peptides
Table 3. Major Manufacturers of Small Molecules
Table 4. Global GnRH Receptor Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global GnRH Receptor Antagonists Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global GnRH Receptor Antagonists Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global GnRH Receptor Antagonists Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global GnRH Receptor Antagonists Revenue Market Share by Region (2018-2024)
Table 9. Global GnRH Receptor Antagonists Revenue Market Share by Region (2024-2029)
Table 10. Global GnRH Receptor Antagonists Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global GnRH Receptor Antagonists Sales by Region (2018-2024) & (K Units)
Table 12. Global GnRH Receptor Antagonists Sales by Region (2024-2029) & (K Units)
Table 13. Global GnRH Receptor Antagonists Sales Market Share by Region (2018-2024)
Table 14. Global GnRH Receptor Antagonists Sales Market Share by Region (2024-2029)
Table 15. Global GnRH Receptor Antagonists Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global GnRH Receptor Antagonists Sales Share by Manufacturers (2018-2024)
Table 17. Global GnRH Receptor Antagonists Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global GnRH Receptor Antagonists Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of GnRH Receptor Antagonists, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. GnRH Receptor Antagonists Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global GnRH Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global GnRH Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GnRH Receptor Antagonists as of 2022)
Table 23. Global Key Manufacturers of GnRH Receptor Antagonists, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of GnRH Receptor Antagonists, Product Offered and Application
Table 25. Global Key Manufacturers of GnRH Receptor Antagonists, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global GnRH Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 28. Global GnRH Receptor Antagonists Sales by Type (2024-2029) & (K Units)
Table 29. Global GnRH Receptor Antagonists Sales Share by Type (2018-2024)
Table 30. Global GnRH Receptor Antagonists Sales Share by Type (2024-2029)
Table 31. Global GnRH Receptor Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global GnRH Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global GnRH Receptor Antagonists Revenue Share by Type (2018-2024)
Table 34. Global GnRH Receptor Antagonists Revenue Share by Type (2024-2029)
Table 35. GnRH Receptor Antagonists Price by Type (2018-2024) & (USD/Unit)
Table 36. Global GnRH Receptor Antagonists Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global GnRH Receptor Antagonists Sales by Application (2018-2024) & (K Units)
Table 38. Global GnRH Receptor Antagonists Sales by Application (2024-2029) & (K Units)
Table 39. Global GnRH Receptor Antagonists Sales Share by Application (2018-2024)
Table 40. Global GnRH Receptor Antagonists Sales Share by Application (2024-2029)
Table 41. Global GnRH Receptor Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global GnRH Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global GnRH Receptor Antagonists Revenue Share by Application (2018-2024)
Table 44. Global GnRH Receptor Antagonists Revenue Share by Application (2024-2029)
Table 45. GnRH Receptor Antagonists Price by Application (2018-2024) & (USD/Unit)
Table 46. Global GnRH Receptor Antagonists Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada GnRH Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada GnRH Receptor Antagonists Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada GnRH Receptor Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada GnRH Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada GnRH Receptor Antagonists Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada GnRH Receptor Antagonists Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada GnRH Receptor Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada GnRH Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada GnRH Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada GnRH Receptor Antagonists Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada GnRH Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada GnRH Receptor Antagonists Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada GnRH Receptor Antagonists Sales by Country (2024-2029) & (K Units)
Table 60. Europe GnRH Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 61. Europe GnRH Receptor Antagonists Sales by Type (2024-2029) & (K Units)
Table 62. Europe GnRH Receptor Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe GnRH Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe GnRH Receptor Antagonists Sales by Application (2018-2024) & (K Units)
Table 65. Europe GnRH Receptor Antagonists Sales by Application (2024-2029) & (K Units)
Table 66. Europe GnRH Receptor Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe GnRH Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe GnRH Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe GnRH Receptor Antagonists Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe GnRH Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe GnRH Receptor Antagonists Sales by Country (2018-2024) & (K Units)
Table 72. Europe GnRH Receptor Antagonists Sales by Country (2024-2029) & (K Units)
Table 73. China GnRH Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 74. China GnRH Receptor Antagonists Sales by Type (2024-2029) & (K Units)
Table 75. China GnRH Receptor Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 76. China GnRH Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 77. China GnRH Receptor Antagonists Sales by Application (2018-2024) & (K Units)
Table 78. China GnRH Receptor Antagonists Sales by Application (2024-2029) & (K Units)
Table 79. China GnRH Receptor Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 80. China GnRH Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia GnRH Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 82. Asia GnRH Receptor Antagonists Sales by Type (2024-2029) & (K Units)
Table 83. Asia GnRH Receptor Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia GnRH Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia GnRH Receptor Antagonists Sales by Application (2018-2024) & (K Units)
Table 86. Asia GnRH Receptor Antagonists Sales by Application (2024-2029) & (K Units)
Table 87. Asia GnRH Receptor Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia GnRH Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia GnRH Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia GnRH Receptor Antagonists Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia GnRH Receptor Antagonists Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia GnRH Receptor Antagonists Sales by Region (2018-2024) & (K Units)
Table 93. Asia GnRH Receptor Antagonists Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America GnRH Receptor Antagonists Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America GnRH Receptor Antagonists Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America GnRH Receptor Antagonists Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America GnRH Receptor Antagonists Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America GnRH Receptor Antagonists Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America GnRH Receptor Antagonists Sales by Country (2024-2029) & (K Units)
Table 107. AbbVie Company Information
Table 108. AbbVie Description and Major Businesses
Table 109. AbbVie GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. AbbVie GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. AbbVie Recent Developments
Table 112. Takeda Company Information
Table 113. Takeda Description and Major Businesses
Table 114. Takeda GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Takeda GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Takeda Recent Developments
Table 117. Astellas Company Information
Table 118. Astellas Description and Major Businesses
Table 119. Astellas GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Astellas GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Astellas Recent Developments
Table 122. Kissei Company Information
Table 123. Kissei Description and Major Businesses
Table 124. Kissei GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Kissei GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Kissei Recent Developments
Table 127. Veru Inc Company Information
Table 128. Veru Inc Description and Major Businesses
Table 129. Veru Inc GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Veru Inc GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Veru Inc Recent Developments
Table 132. Myovant Sciences Company Information
Table 133. Myovant Sciences Description and Major Businesses
Table 134. Myovant Sciences GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Myovant Sciences GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Myovant Sciences Recent Developments
Table 137. AstraZeneca Company Information
Table 138. AstraZeneca Description and Major Businesses
Table 139. AstraZeneca GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. AstraZeneca GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. AstraZeneca Recent Developments
Table 142. Ferring Pharmaceuticals Company Information
Table 143. Ferring Pharmaceuticals Description and Major Businesses
Table 144. Ferring Pharmaceuticals GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Ferring Pharmaceuticals GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Ferring Pharmaceuticals Recent Developments
Table 147. Jiangsu Hengrui Medicine Co Company Information
Table 148. Jiangsu Hengrui Medicine Co Description and Major Businesses
Table 149. Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Jiangsu Hengrui Medicine Co Recent Developments
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. GnRH Receptor Antagonists Distributors List
Table 155. GnRH Receptor Antagonists Customers List
Table 156. GnRH Receptor Antagonists Market Trends
Table 157. GnRH Receptor Antagonists Market Drivers
Table 158. GnRH Receptor Antagonists Market Challenges
Table 159. GnRH Receptor Antagonists Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. GnRH Receptor Antagonists Product Picture
Figure 2. Global GnRH Receptor Antagonists Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global GnRH Receptor Antagonists Market Share by Type in 2022 & 2029
Figure 4. Peptides Product Picture
Figure 5. Small Molecules Product Picture
Figure 6. Global GnRH Receptor Antagonists Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global GnRH Receptor Antagonists Market Share by Application in 2022 & 2029
Figure 8. Prostate Cancer
Figure 9. Endometriosis
Figure 10. Uterine Fibroids
Figure 11. Female Infertility
Figure 12. Others
Figure 13. GnRH Receptor Antagonists Report Years Considered
Figure 14. Global GnRH Receptor Antagonists Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global GnRH Receptor Antagonists Revenue 2018-2029 (US$ Million)
Figure 16. Global GnRH Receptor Antagonists Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global GnRH Receptor Antagonists Revenue Market Share by Region (2018-2029)
Figure 18. Global GnRH Receptor Antagonists Sales 2018-2029 ((K Units)
Figure 19. Global GnRH Receptor Antagonists Sales Market Share by Region (2018-2029)
Figure 20. US & Canada GnRH Receptor Antagonists Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada GnRH Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe GnRH Receptor Antagonists Sales YoY (2018-2029) & (K Units)
Figure 23. Europe GnRH Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China GnRH Receptor Antagonists Sales YoY (2018-2029) & (K Units)
Figure 25. China GnRH Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) GnRH Receptor Antagonists Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) GnRH Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America GnRH Receptor Antagonists Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The GnRH Receptor Antagonists Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of GnRH Receptor Antagonists in the World: Market Share by GnRH Receptor Antagonists Revenue in 2022
Figure 32. Global GnRH Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global GnRH Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 34. Global GnRH Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 35. Global GnRH Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 36. Global GnRH Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada GnRH Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 38. US & Canada GnRH Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada GnRH Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 40. US & Canada GnRH Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada GnRH Receptor Antagonists Revenue Share by Country (2018-2029)
Figure 42. US & Canada GnRH Receptor Antagonists Sales Share by Country (2018-2029)
Figure 43. U.S. GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 44. Canada GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 45. Europe GnRH Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 46. Europe GnRH Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 47. Europe GnRH Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 48. Europe GnRH Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 49. Europe GnRH Receptor Antagonists Revenue Share by Country (2018-2029)
Figure 50. Europe GnRH Receptor Antagonists Sales Share by Country (2018-2029)
Figure 51. Germany GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 52. France GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 54. Italy GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 55. Russia GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 56. China GnRH Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 57. China GnRH Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 58. China GnRH Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 59. China GnRH Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 60. Asia GnRH Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 61. Asia GnRH Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 62. Asia GnRH Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 63. Asia GnRH Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 64. Asia GnRH Receptor Antagonists Revenue Share by Region (2018-2029)
Figure 65. Asia GnRH Receptor Antagonists Sales Share by Region (2018-2029)
Figure 66. Japan GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 70. India GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America GnRH Receptor Antagonists Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America GnRH Receptor Antagonists Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America GnRH Receptor Antagonists Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America GnRH Receptor Antagonists Sales Share by Country (2018-2029)
Figure 77. Brazil GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 80. Israel GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries GnRH Receptor Antagonists Revenue (2018-2029) & (US$ Million)
Figure 82. GnRH Receptor Antagonists Value Chain
Figure 83. GnRH Receptor Antagonists Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries